Article

A Reliable Option for Reversing Morning Akinesia for Patients With Parkinson Disease

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Pamela Zeilman, NP
Esther Labib-Kiyarash, MSHA, CPHQ
Justin Martello, MD
William Ondo, MD
Jennifer Corcoran, MD
Marcia Pasqualini, PhD
Anissa Mitchell, LCSW
Related Content
Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time
July 3rd 2025

Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time

Marco Meglio
Episode 144: Differentiating Dravet and Lennox-Gastaut: Diagnosis, Research, and What’s Ahead
June 27th 2025

Episode 144: Differentiating Dravet and Lennox-Gastaut: Diagnosis, Research, and What’s Ahead

Marco Meglio Joseph Sullivan, MD
Switch From Amantadine Immediate-Release to Gocovri Results in Improved Real-World Parkinson Disease Benefits
July 3rd 2025

Switch From Amantadine Immediate-Release to Gocovri Results in Improved Real-World Parkinson Disease Benefits

Marco Meglio
Episode 143: Bemdaneprocel and the Future of Cell Therapy in Parkinson Disease
June 13th 2025

Episode 143: Bemdaneprocel and the Future of Cell Therapy in Parkinson Disease

Marco Meglio Rajesh Pahwa, MD
Long-Term 4-Year Data Highlights Sustained Effects of Deramiocel in DMD Cardiomyopathy
July 2nd 2025

Long-Term 4-Year Data Highlights Sustained Effects of Deramiocel in DMD Cardiomyopathy

Marco Meglio
NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease
July 2nd 2025

NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease

Isabella Ciccone, MPH Cheryl Kyinn, PA-C
© 2025 MJH Life Sciences

All rights reserved.